Lambda Stock
| Valuation | $5.9B1 |
| Valuation Date | Nov 18, 2025 |
| Implied Valuation | $4.44B |
| Last Price | $40.81 |
| 52-Week High | $75.68 |
| 52-Week Low | $23.26 |
| YTD Return | -27.97% |
| 1-Year Return | +75.45% |
| 3-Year Return | n/a |
| Total Funding | n/a |
| Latest Round Amount | $1.5B2 |
| Latest Round | Series E |
| Funding Rounds | 6 |
| IPO Status | Expected3 |
| Expected IPO Date | H2 2026 |
| Revenue | $520M4 |
| Revenue Type | TTM |
| P/S Ratio | 11.3 |
About Lambda
Lambda is a cloud computing company that provides GPU infrastructure for training, fine-tuning, and running artificial intelligence models. It rents on-demand access to Nvidia GPUs through its cloud platform and builds large-scale data centers for frontier labs, enterprises, and hyperscalers. The company also offers managed inference and developer tools, including its Inference API and the Lambda Chat assistant. Lambda makes money primarily by charging customers for GPU compute time and through large, multi-year cloud capacity contracts.
Invest in Lambda
Want to invest in Lambda? Try our partner below.
Hiive is a marketplace for buying and selling shares of private, pre-IPO companies. Invest in the world's most exciting startups before they go public.
Invest on HiiveStock Analysis may be compensated for user sign-ups through Hiive links. Hiive is not affiliated with Stock Analysis. Securities offered by Hiive Markets Limited, member of FINRA/SIPC.
News
Lambda Partners with Hudson River Trading to Power Quantitative Research and Development
SAN FRANCISCO--(BUSINESS WIRE)--Lambda, The Superintelligence Cloud, today announced a partnership with Hudson River Trading (HRT), a leading quantitative trading firm, to accelerate HRT's trading res...
Lambda Closes $1 Billion Senior Secured Credit Facility to Meet Gigawatt-Scale AI Infrastructure Demand
SAN FRANCISCO--(BUSINESS WIRE)--Lambda, the Superintelligence Cloud, today announced the closing of a $1 billion syndicated senior secured credit facility. The financing upsizes Lambda's existing cred...
Lambda Assembles Leadership Team to Power Gigawatt-Scale AI Infrastructure for the Superintelligence Era
SAN FRANCISCO--(BUSINESS WIRE)--Lambda, the Superintelligence Cloud, today announced an expanded leadership structure assembled to match the scale of the opportunity in front of the company. As demand...
Lambda Expands NVIDIA Collaboration, Large-Scale Deployments, and New AI Infrastructure Offerings
SAN FRANCISCO--(BUSINESS WIRE)--Lambda, the Superintelligence Cloud, today announced at NVIDIA GTC 2026 it is a launch partner for NVIDIA's Vera CPU platform and NVIDIA STX, the deployment of NVIDIA Q...
Lambda Leads Early Adoption of NVIDIA Co-Packaged Optics for Next-Gen AI Factories
SAN FRANCISCO--(BUSINESS WIRE)--Lambda, the Superintelligence Cloud, today announced it is among the first AI infrastructure providers to integrate NVIDIA's silicon photonics–based networking. The shi...
Lambda is One of the First to Deploy NVIDIA Co-Packaged Optics for AI Infrastructure
SAN FRANCISCO--(BUSINESS WIRE)--Lambda, the Superintelligence Cloud, today announced it is among the first AI infrastructure providers to integrate NVIDIA's silicon photonics–based networking. The shi...
AI Cloud Company Lambda Raises Over $1.5 Billion
Lambda, a startup that rents out access to advanced artificial intelligence chips, said Tuesday that it raised over $1.5 billion in its latest funding round.
Lambda inks multi-billion-dollar AI infrastructure deal with Microsoft
Cloud-computing company Lambda deepened its relationship with Microsoft through a sizable AI infrastructure deal.
Lambda, Microsoft agree to multibillion-dollar AI infrastructure deal with Nvidia chips
AI cloud startup Lambda announced a multibillion-dollar partnership with Microsoft to build AI infrastructure powered by Nvidia chips. The Nvidia-backed firm has had a relationship with Microsoft sinc...
Cloud startup Lambda unveils multi-billion-dollar deal with Microsoft
Artificial intelligence cloud startup Lambda said on Monday it has entered into a multi-billion-dollar agreement with Microsoft to deploy tens of thousands of AI chip leader Nvidia's graphics processo...
Lambda Announces Multibillion-Dollar Agreement With Microsoft to Deploy AI Infrastructure Powered by Tens of Thousands of NVIDIA GPUs
SAN FRANCISCO--(BUSINESS WIRE)--Lambda, the Superintelligence Cloud, today announced a multibillion-dollar agreement with Microsoft to deploy AI infrastructure powered by tens of thousands of NVIDIA G...
Lambda Achieves NVIDIA Exemplar Cloud
SAN FRANCISCO--(BUSINESS WIRE)--Lambda, the Superintelligence Cloud, today announced it has achieved NVIDIA Exemplar Cloud Status, becoming one of the first GPU cloud providers worldwide to receive pe...
Lambda Appoints Heather Planishek to Board of Directors as Audit Chair
SAN FRANCISCO--(BUSINESS WIRE)--Lambda, the Superintelligence Cloud, today announced the appointment of Heather Planishek to its Board of Directors, where she will serve as Audit Chair. Planishek brin...
Lambda and ECL Bring the First Hydrogen-Powered NVIDIA GB300 NVL72 Systems Online
SAN FRANCISCO--(BUSINESS WIRE)--Lambda, the Superintelligence Cloud, today announced the deployment of the industry's first hydrogen-powered, production-grade NVIDIA GB300 NVL72 systems at ECL's Mount...
Lambda Builds AI Factories with Supermicro NVIDIA Blackwell GPU Server Clusters to Deliver Production-ready Next-Gen AI Infrastructure at Scale
Expanded AI infrastructure with faster results with Supermicro's GPU-optimized servers Large-scale AI factories for training and inference deployed in record time Supermicro's advanced liquid-cooling ...
Cybernet and Nokia redefine Pakistan's network landscape with 1.2T-per-lambda backbone
Press ReleaseCybernet and Nokia redefine Pakistan's network landscape with 1.2T-per-lambda backbone Cybernet has selected Nokia's innovative 1830 Global Express (GX) platform with integrated optical l...
AI cloud startup Lambda raises $480 million in new round; Nvidia among investors
Lambda, a cloud computing firm specializing in providing hardware and services to power artificial intelligence development, has raised $480 million in a Series D equity round from investors including...
Lambda Announces Strategic Partnership with SK Telecom to Expand Cloud Services in South Korea
SAN JOSE, Calif.--(BUSINESS WIRE)--Lambda, the AI developer cloud, today announced a partnership with South Korea's largest mobile telecommunications company, SK Telecom (SKT). Amid increasing demand ...
Lambda Launches First Self-Serve, On-Demand NVIDIA HGX H100 and NVIDIA Quantum-2 InfiniBand Clusters for AI Model Training
SAN JOSE, Calif.--(BUSINESS WIRE)--Lambda, the GPU cloud company founded by AI engineers and powered by NVIDIA GPUs, has unveiled Lambda 1-Click Clusters, providing AI engineers and researchers short-...
Lambda secures $500 mln loan with Nvidia chips as collateral
Lambda has secured a $500 million loan from lenders including Macquarie Group with Nvidia's much-coveted chips as collateral, the specialty artificial intelligence cloud provider said on Thursday.
PhenomeX Announces the Release of SpotLight™ Human Lambda Reagent for the Beacon® Platform to Accelerate Cell Line Development Workflows
Preliminary SpotLight™ Human Lambda reagent data to be showcased by GSK at the 16th annual PEACe Conference EMERYVILLE, Calif. , Sept. 21, 2023 /PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), a function...
Eiger to Discontinue Phase 3 LIMT-2 Trial of Peginterferon Lambda in Patients with Chronic Hepatitis Delta
PALO ALTO, Calif., Sept. 12, 2023 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies for rare...
Rekor Systems and Tel Aviv University LAMBDA Partner to Push the Frontiers of AI-based Roadway Intelligence
Strategic academic collaboration integrates Tel Aviv University into the Rekor Partner Network, strengthening the global ecosystem of technology and solution providers revolutionizing roadway intellig...
BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA AND LAMBDA LIGHT CHAINS mRNA
MINNEAPOLIS , May 10, 2023 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communit...
New England Journal of Medicine Publishes Positive Phase 3 TOGETHER Results with Peginterferon Lambda in COVID-19
- Phase 3 TOGETHER data showed early treatment with a single dose of peginterferon lambda (Lambda) in patients with mild-to-moderate COVID-19 infections resulted in significantly decreased clinical e...
New Relic Releases Add-Ons for AWS Compute Optimizer, AWS Lambda Extensions, and AWS App Runner
LAS VEGAS--(BUSINESS WIRE)--New Relic (NYSE: NEWR), the all-in-one observability platform for every engineer, announced at Amazon Web Services (AWS) re:Invent 2022 support for AWS Compute Optimizer,...
Eiger BioPharmaceuticals Provides Update on Status of Planned Peginterferon Lambda COVID-19 Emergency Use Authorization Application
PALO ALTO, Calif. , Sept. 6, 2022 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies for hepa...
Eiger's Single-dose Peginterferon Lambda for COVID-19 Reduced Risk of Hospitalization or ER Visits by 50% in a Predominantly Vaccinated Population in Phase 3 TOGETHER Study
Second largest study to date in COVID-19 outpatients (N=1,936) Highly superior compared to placebo, with a probability of superiority of 99.91% on the primary endpoint 60% reduced risk of COVID-19-rel...
Eiger BioPharmaceuticals to Host Conference Call to Discuss Phase 3 TOGETHER Study Results of Peginterferon Lambda for COVID-19 on Thursday, March 17, 2022
Live Conference Call and Webcast at 5:30 AM Pacific / 8:30 AM Eastern PALO ALTO, Calif., March 16, 2022 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutic...
Transphorm and TDK-Lambda Announce Expansion of AC-DC GaN Power Module Family
GOLETA, Calif.--(BUSINESS WIRE)---- $TGAN #5G--Transphorm GaN PQFN devices power TDK's family of PFH 500W modules, delivering a 38% power density increase over silicon-based modules.
Eiger BioPharmaceuticals Announces First Patient Enrolled in LIMT-2: A Phase 3 Study of Peginterferon Lambda in Patients with Chronic Hepatitis Delta Virus (HDV) Infection
PALO ALTO, Calif., Dec. 21, 2021 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies to treat ...
Eiger BioPharmaceuticals Announces Second Positive Interim Analysis and Continuation of Dosing of Peginterferon Lambda in Phase 3 TOGETHER Study of Newly Diagnosed COVID-19 Patients
PALO ALTO, Calif., Dec. 15, 2021 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies to treat ...
Sumo Logic Drives Unified Observability with Expanded Tracing Visibility into AWS Lambda
Powered by OpenTelemetry, Sumo Logic Platform Enhancements Deliver Unparalleled Insight Into Application Performance
Eiger BioPharmaceuticals Announces Interim Analysis and Continuation of Dosing of Peginterferon Lambda in Phase 3 TOGETHER Study of Newly Diagnosed COVID-19 Outpatients
PALO ALTO, Calif., Sept. 20, 2021 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development and commercialization of target...
Globe Telecom Upgrades Network for 5G with Infinera's Auto-Lambda Solution
SAN JOSE, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Infinera (NASDAQ: INFN) announced today that Globe Telecom, Inc. (Globe), a major provider of telecom services in the Philippines, deployed Infiner...
Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes SARS-CoV-2 Lambda and Delta Plus Variants in Pre-clinical Testing
EXTON, Pa.--(BUSINESS WIRE)--Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes SARS-CoV-2 Lambda and Delta Plus Variants in Pre-clinical Testing
SAB Biotherapeutics Announces Nonclinical Data Demonstrating SAB-185 Potently Neutralizes Delta and Lambda SARS-CoV-2 Variants
SIOUX FALLS, S.D.--(BUSINESS WIRE)---- $BCYP #BCYP--SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-...
Eiger BioPharmaceuticals Announces First Patients Dosed with Peginterferon Lambda in Phase 3 TOGETHER Study of Newly Diagnosed COVID-19 Outpatients
PALO ALTO, Calif., July 6, 2021 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development and commercialization of targeted ...
Datadog Extension for AWS Lambda Now Generally Available
NEW YORK, May 24, 2021 /PRNewswire/ -- Datadog , Inc. (NASDAQ: DDOG), the monitoring and security platform for cloud applications, today announced the general availability of Datadog's AWS Lambda exte...
Eiger BioPharmaceuticals Announces Peginterferon Lambda to be Added to Multi-Center Phase 3 TOGETHER COVID-19 Study in Brazil
PALO ALTO, Calif., May 3, 2021 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development and commercialization of targeted t...
Eiger Announces Case Studies Demonstrating Regression of Liver Fibrosis Following 48 Weeks of Therapy with Peginterferon Lambda in Patients with Chronic Hepatitis Delta Virus (HDV) Infection Presented at The Liver Meeting Digital Experience™ 2020
PALO ALTO, Calif., Nov. 16, 2020 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of first-in-class therapies for serious rare and ultra-...
Eiger Announces Abstracts Highlighting Peginterferon Lambda and Lonafarnib in Chronic Hepatitis Delta Virus (HDV) Infection Accepted for Presentation at The Liver Meeting Digital Experience™ 2020
PALO ALTO, Calif., Nov. 2, 2020 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted, first-in-class therapies for serious rare an...
Eiger Announces Peginterferon Lambda - Lonafarnib Combination End of Treatment Results from Phase 2 LIFT HDV Study in Late Breaker Session at The Digital International Liver Congress™ 2020
PALO ALTO, Calif., Aug. 31, 2020 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc.